Stock Track | Chemed Soars 6.02% in Post-Market Trading on Strong Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track
04/24

Chemed's stock surged 6.02% in post-market trading on Thursday, following the release of its first-quarter 2026 financial results that exceeded analyst expectations.

The healthcare and plumbing services company reported adjusted earnings of $5.65 per share, beating the consensus estimate of $5.30. Revenue for the quarter reached $657.5 million, also surpassing expectations of $649.8 million.

Chemed raised its full-year 2026 adjusted EPS guidance to a range of $24.00 to $24.75, up from the previous range of $23.25 to $24.25. The company attributed the strong performance to increased admissions at its VITAS hospice segment, which grew 6.9%, and also raised revenue growth guidance for both its VITAS and American Drain Cleaning segments.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10